autosomal recessive limb-girdle muscular dystrophy type 2C
autosomal recessive limb-girdle muscular dystrophy type 2C
Explore linked clinical trials. Standard reference: MONDO:00096773 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Labyrinthin Vaccination in Veterans With Lung Adenocarcinoma | Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, autosomal recessive limb-girdle muscular dystrophy type 2C, carcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Phase 2 | 2026-10-06 | NCT07859592 | |
| ATA-200 Gene Therapy Trial in Patients With LGMDR5 | autosomal recessive limb-girdle muscular dystrophy type 2C | Active, not recruiting | Phase 1 | 2026-01-29 | NCT05973630 | |
| Long-Term Development of Muscular Dystrophy Outcome Assessments | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Emery-Dreifuss muscular dystrophy 2, autosomal dominant, Eye Diseases, Hereditary, Limb-girdle muscular dystrophy, type 2E, Malformations of Cortical Development, Group II, Muscular Disorders, Atrophic, Muscular Dystrophy, Limb-Girdle, Type 1C, Muscular Dystrophy, Limb-Girdle, Type 1E, Respiration Disorders, autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), autosomal dominant limb-girdle muscular dystrophy type 1F, autosomal dominant limb-girdle muscular dystrophy type 1G, autosomal dominant limb-girdle muscular dystrophy type 1H, autosomal recessive limb-girdle muscular dystrophy type 2A, autosomal recessive limb-girdle muscular dystrophy type 2B, autosomal recessive limb-girdle muscular dystrophy type 2C, autosomal recessive limb-girdle muscular dystrophy type 2F, autosomal recessive limb-girdle muscular dystrophy type 2G, autosomal recessive limb-girdle muscular dystrophy type 2I, autosomal recessive limb-girdle muscular dystrophy type 2J, autosomal recessive limb-girdle muscular dystrophy type 2L, autosomal recessive limb-girdle muscular dystrophy type 2M, autosomal recessive limb-girdle muscular dystrophy type 2N, autosomal recessive limb-girdle muscular dystrophy type 2O, autosomal recessive limb-girdle muscular dystrophy type 2P, autosomal recessive limb-girdle muscular dystrophy type 2Q, autosomal recessive limb-girdle muscular dystrophy type 2T, autosomal recessive limb-girdle muscular dystrophy type 2U, autosomal recessive limb-girdle muscular dystrophy type 2W, autosomal recessive limb-girdle muscular dystrophy type 2X, autosomal recessive limb-girdle muscular dystrophy type 2Y, autosomal recessive limb-girdle muscular dystrophy type R18, cardiomyopathy, cardiovascular disorder, central nervous system malformation, cerebral cortical dysplasia, cobblestone lissencephaly, eye disorder, heart disorder, hereditary disease, inherited neurodegenerative disorder, limb-girdle muscular dystrophy, lissencephaly spectrum disorders, muscle tissue disorder, muscular dystrophy, muscular dystrophy-dystroglycanopathy, type A, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease, respiratory system disorder, sarcoglycanopathy | Recruiting | Not stated | 2025-11-18 | NCT05989620 |